Tafolecimab API Manufacturers

compare suppliers & get competitive offers

Pharmaoffer_donkere_achtergrond
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Tafolecimab is listed?

Join our notification list by following this page.

List your company
Are you a supplier of Tafolecimab or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

Looking for Tafolecimab API 2225109-03-3?

Description:
Here you will find a list of producers, manufacturers and distributors of Tafolecimab. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Tafolecimab 
Synonyms:
Immunoglobulin igg2, anti-(human proprotein convertase subtilisin/kexin type 9) (human monoclonal ibi306 .gamma.2-chain), disulfide with human monoclonal ibi306 .kappa.-chain, dimer , Tafolecimab  
Cas Number:
2225109-03-3 
DrugBank number:
DB16336 
Unique Ingredient Identifier:
KV2ZKH0NIM

General Description:

Tafolecimab, identified by CAS number 2225109-03-3, is a notable compound with significant therapeutic applications. Tafolecimab is under investigation in clinical trial NCT04031742 (A Study to Evaluate Safety and Efficacy of IBI306, a PCSK9 Monoclonal Antibody in Chinese Subjects With Homozygous Familial Hypercholesterolemia).